Abstract

Cellular competition for limiting hematopoietic factors is a physiologically regulated but poorly understood process. Here, we studied this phenomenon by hampering hematopoietic progenitor access to Leptin receptor+ mesenchymal stem/progenitor cells (MSPCs) and endothelial cells (ECs). We show that HSC numbers increase by 2-fold when multipotent and lineage-restricted progenitors fail to respond to CXCL12 produced by MSPCs and ECs. HSCs are qualitatively normal, and HSC expansion only occurs when early hematopoietic progenitors but not differentiated hematopoietic cells lack CXCR4. Furthermore, the MSPC and EC transcriptomic heterogeneity is stable, suggesting that it is impervious to major changes in hematopoietic progenitor interactions. Instead, HSC expansion correlates with increased availability of membrane-bound stem cell factor (mSCF) on MSPCs and ECs presumably due to reduced consumption by cKit-expressing hematopoietic progenitors. These studies suggest that an intricate homeostatic balance between HSCs and proximal hematopoietic progenitors is regulated by cell competition for limited amounts of mSCF.

Hematopoietic stem cells (HSCs) rely on a combination of paracrine signals produced by their niche, including SCF. Here the authors show that HSCs and hematopoietic progenitors compete for limited amounts of membrane-bound SCF.

Details

Title
Competition between hematopoietic stem and progenitor cells controls hematopoietic stem cell compartment size
Author
Miao, Runfeng 1 ; Chun, Harim 2 ; Feng, Xing 1 ; Gomes, Ana Cordeiro 3 ; Choi, Jungmin 4   VIAFID ORCID Logo  ; Pereira, João P. 1   VIAFID ORCID Logo 

 Yale University School of Medicine, Department of Immunobiology and Yale Stem Cell Center, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710) 
 Korea University College of Medicine, BK21 Graduate Program, Department of Biomedical Sciences, Seoul, Republic of Korea (GRID:grid.222754.4) (ISNI:0000 0001 0840 2678) 
 Yale University School of Medicine, Department of Immunobiology and Yale Stem Cell Center, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710); i3S – Instituto de Investigação e Inovação em Saúde, University of Porto, Porto, Portugal (GRID:grid.5808.5) (ISNI:0000 0001 1503 7226) 
 Korea University College of Medicine, BK21 Graduate Program, Department of Biomedical Sciences, Seoul, Republic of Korea (GRID:grid.222754.4) (ISNI:0000 0001 0840 2678); Yale University School of Medicine, Department of Genetics, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2699838444
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.